retatrutide side effects clinical trial results 2024 2025 Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials HEALTH FIRST: New Medicare juniper Weight Loss Program type:Tirzepatide (GLP-1 + GIP)

retatrutide side effects clinical trial results 2024 2025 Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials HEALTH FIRST: New Medicare juniper Weight Loss Program type:Tirzepatide (GLP-1 + GIP)

HEALTH FIRST: New Medicare program offers low-cost GLP-1 weight loss drugs ⬇️

This tailored potency profile is designed to balance efficacy across all three pathways while managing the safety considerations of each receptor's activation

juniper

Weight Loss Program type:Tirzepatide (GLP-1 + GIP)

ADA Meeting News